221 related articles for article (PubMed ID: 20494126)
1. Advances in eicosanoid research, novel therapeutic implications.
Haeggström JZ; Rinaldo-Matthis A; Wheelock CE; Wetterholm A
Biochem Biophys Res Commun; 2010 May; 396(1):135-9. PubMed ID: 20494126
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandins and leukotrienes: advances in eicosanoid biology.
Funk CD
Science; 2001 Nov; 294(5548):1871-5. PubMed ID: 11729303
[TBL] [Abstract][Full Text] [Related]
3. [Modulation of leukotriene pathway - potential targets].
Peter H; Lýdia B
Ceska Slov Farm; 2012 Jun; 61(3):101-6. PubMed ID: 22913825
[TBL] [Abstract][Full Text] [Related]
4. Heart disease. Gene suggests asthma drugs may ease cardiovascular inflammation.
Wickelgren I
Science; 2004 Feb; 303(5660):941. PubMed ID: 14963296
[No Abstract] [Full Text] [Related]
5. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
Rubin P; Mollison KW
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
[TBL] [Abstract][Full Text] [Related]
7. Enzymes and receptors in the leukotriene cascade.
Haeggström JZ; Wetterholm A
Cell Mol Life Sci; 2002 May; 59(5):742-53. PubMed ID: 12088275
[TBL] [Abstract][Full Text] [Related]
8. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
Sharma JN; Mohammed LA
Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
[TBL] [Abstract][Full Text] [Related]
9. [The significance of leukotrienes in pathophysiology of bronchial asthma--therapy perspectives].
Wojnowski P; Patkowski J
Postepy Hig Med Dosw; 1997; 51(5):499-514. PubMed ID: 9489451
[TBL] [Abstract][Full Text] [Related]
10. Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.
Mirshafiey A; Jadidi-Niaragh F
Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):219-27. PubMed ID: 20298145
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis.
Pérez-Novo CA; Watelet JB; Claeys C; Van Cauwenberge P; Bachert C
J Allergy Clin Immunol; 2005 Jun; 115(6):1189-96. PubMed ID: 15940133
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.
Bäck M
Curr Pharm Des; 2009; 15(27):3116-32. PubMed ID: 19754386
[TBL] [Abstract][Full Text] [Related]
13. Eicosanoids: lipid mediators of inflammation in transplantation.
Rocha PN; Plumb TJ; Coffman TM
Springer Semin Immunopathol; 2003 Sep; 25(2):215-27. PubMed ID: 12955468
[TBL] [Abstract][Full Text] [Related]
14. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease.
Rådmark O; Werz O; Steinhilber D; Samuelsson B
Biochim Biophys Acta; 2015 Apr; 1851(4):331-9. PubMed ID: 25152163
[TBL] [Abstract][Full Text] [Related]
15. Modulators of leukotriene biosynthesis and receptor activation.
Brooks CD; Summers JB
J Med Chem; 1996 Jul; 39(14):2629-54. PubMed ID: 8709092
[No Abstract] [Full Text] [Related]
16. Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis.
Rådmark O; Samuelsson B
Biochem Biophys Res Commun; 2010 May; 396(1):105-10. PubMed ID: 20494120
[TBL] [Abstract][Full Text] [Related]
17. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
Parker AR; Ayars AG; Altman MC; Henderson WR
Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
[TBL] [Abstract][Full Text] [Related]
18. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy.
Lill AP; Rödl CB; Steinhilber D; Stark H; Hofmann B
Eur J Med Chem; 2015 Jan; 89():503-23. PubMed ID: 25462262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
